Pharma drama in pennyland? What's unique about SNPK is that it has the aura of being a pharma stock. Not that it is one. But think of it. Drug companies sell stock to finance etc., go into big debt, bleed revinue big time hoping that after yrs. they can sell a drug. Here we have a pill to fill a percieved nich with a huge population, and no development costs etc. It's producing revenue now. But it's never been truley promoted big. Just thought there is a rough parallel here in concept/principle at least. Yes it's a promo, but doesn't big pharma prep then launch a big sales drive when they get approved? Goofy thought I know but and interesting one. I've seen 1 pharma go from a $1 to 16 back to 9 then bought out for 26 and they never made one dime in profit on the drug. the co that bought them has yrs to go yet if they ever see anything for their efforts.
Market Data 
Markets 
AI
